Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 14.19B P/E 23.36 EPS this Y -5.70% Ern Qtrly Grth -
Income 360.2M Forward P/E 17.09 EPS next Y 21.00% 50D Avg Chg 2.00%
Sales 6.83B PEG 3.68 EPS past 5Y 9.75% 200D Avg Chg -1.00%
Dividend N/A Price/Book 2.83 EPS next 5Y 6.90% 52W High Chg -28.00%
Recommedations 2.20 Quick Ratio 0.97 Shares Outstanding 679.84M 52W Low Chg 17.00%
Insider Own 1.25% ROA 3.67% Shares Float 676.88M Beta 1.33
Inst Own 98.26% ROE 6.90% Shares Shorted/Prior 35.21M/36.39M Price 21.02
Gross Margin 33.71% Profit Margin 5.28% Avg. Volume 6,115,253 Target Price 27.95
Oper. Margin 10.36% Earnings Date Oct 25 Volume 5,186,418 Change 0.62%
About Avantor, Inc.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Avantor, Inc. News
11/20/24 Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
11/15/24 The three-year shareholder returns and company earnings persist lower as Avantor (NYSE:AVTR) stock falls a further 8.0% in past week
11/14/24 Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
11/07/24 MD vs. AVTR: Which Stock Is the Better Value Option?
11/06/24 Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
10/28/24 Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
10/26/24 Avantor Third Quarter 2024 Earnings: EPS Misses Expectations
10/26/24 Avantor Inc (AVTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Resilience
10/26/24 Decoding Avantor Inc (AVTR): A Strategic SWOT Insight
10/25/24 Q3 2024 Avantor Inc Earnings Call
10/25/24 Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10/25/24 Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates
10/25/24 Avantor® Reports Third Quarter 2024 Results
07:05 AM Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
10/21/24 AVTR Stock Flat Following the Close of Divestiture Deal With Audax
10/18/24 Avantor® Closes Previously Announced Divestiture of its Clinical Services Business
10/09/24 Solid Execution Lifted Avantor (AVTR) in Q3
10/02/24 MD vs. AVTR: Which Stock Should Value Investors Buy Now?
09/30/24 Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management
09/27/24 Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024
AVTR Chatroom

User Image Benzinga Posted - 2 days ago

Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis $NVDA $QSI $AVTR https://www.benzinga.com/general/health-care/24/11/42091430/nvidia-partners-with-quantum-si-to-advance-single-molecule-analysis

User Image Avocado_smash Posted - 4 days ago

$AVTR 18.95

User Image belegendary Posted - 4 days ago

$AVTR still sitting at this major support.

User Image TeresaTrades Posted - 4 days ago

Largest PUT OI increases $AVTR $BBD $NVDA $MAZN $SMCI

User Image belegendary Posted - 6 days ago

$AVTR Some interesting flow came through $19p 01/17/25 for $1.2 million at the bid. We are at strong daily support. I might take a lotto 25c 01/17/2025 ($0.50/con) https://unusualwhales.com/flow/option_chains?chain=AVTR250117C00022500&days=1&mins=5& On the weekly it does look like we broke a rising wedge. I could see us go down to 17.79

User Image Coleperris55 Posted - 1 week ago

$AVTR Double bottom on daily. Expecting a bounce. 🚀🔥📈

User Image TeresaTrades Posted - 1 week ago

Heavy options volume $AVTR $SQQQ $CCK $LW $TMC

User Image smartkarma Posted - 1 week ago

$AVTR | Avantor Inc.: Its Expansion in Bioprocessing Driving Our ‘Outperform’ Rating! - Major Drivers "Avantor Inc. reported another quarter of stability and mixed results in its financial performance for the third quarter of 2024. The company..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/avantor-inc-its-expansion-in-bioprocessing-driving-our-outperform-rating-major-drivers

User Image ChristaBoarts Posted - 1 week ago

$AVTR Innovative medical technology and IP protection make IBO a stock to watch for growth.

User Image judgeyoung2 Posted - 10/29/24

@ribbey @indievestments @Ollip @Alvi722 @cubie @jenbunn @EBE_Day @TraderRapp @tonyctl @lukenight I like $AVTR puts from your scanner ribbey. Charts looks weak.

User Image TeresaTrades Posted - 10/29/24

Largest PUT OI increases $NU $FLG $F $GFC $AVTR

User Image Thestocktraderhubzee Posted - 10/28/24

WATCHLIST OCT 29 2024. $AVTR Wells Fargo Maintains Overweight on Avantor, Lowers Price Target to $28 $NOV TD Cowen Maintains Buy on NOV, Lowers Price Target to $22 $BCDA HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target $CRGY Stephens & Co. Maintains Overweight on Crescent Energy, Raises Price Target to $16 $ELAN Barclays Maintains Overweight on Elanco Animal Health, Lowers Price Target to $19

User Image FilingFact Posted - 10/28/24

New financial insights available on https://www.filingfact.com/ from Fridays report of $AVTR With the launch of the new platform we are offering 1 month of FREE Premium Access (worth $49) to the first 100 users! 🥳 💬 We’d love to hear your thoughts—your feedback will help us improving our service to your needs! For any questions, ideas, or support, reach out to us at [email protected] 👉 Join today and be a part of the journey!

User Image Thestocktraderhubzee Posted - 10/28/24

$AVTR Wells Fargo Maintains Overweight on Avantor, Lowers Price Target to $28

User Image TeresaTrades Posted - 10/28/24

Largest PUT OI increases $AVTR $SMCI $WBD $KVUE $NVDA

User Image Thestocktraderhubzee Posted - 10/28/24

$AVTR Baird Maintains Outperform on Avantor, Lowers Price Target to $26

User Image EarningsCentral Posted - 10/27/24

$AVTR Earnings Call Recap for Q3 2024 https://youtu.be/mvhJdjMta7o

User Image DonCorleone77 Posted - 10/26/24

$AVTR Avantor price target lowered to $26 from $28 at Goldman Sachs Goldman Sachs lowered the firm's price target on Avantor to $26 from $28 and keeps a Buy rating on the shares after its Q3 results and affirmed guidance. The firm notes that it was "pleased" with the strong free cash flow generation in the quarter and the gradual improvement in bioprocessing and equipment & instrumentation revenue which exceeded its expectations coming into the quarter, and while the management is not providing guidance on 2025, Goldman is assuming a continuation of a slow and steady improvement throughout the FY2, the analyst tells investors in a research note.

User Image G101SPM Posted - 10/25/24

#OPTIONACTION $RUN Nov 18 calls (volume: 40.8K, open int: 6.9K, implied vol: ~114%, prev day implied vol: 67%). Co is confirmed to report earnings November 7 after the close. $GME Weeky Oct25 21 calls (volume: 19.3K, open int: 15.2K, implied vol: ~63%, prev day implied vol: 53%). Co is expected to report earnings early December. DXCM Weekly Nov01 80 calls (volume: 2.2K, open int: 510, implied vol: ~43%, prev day implied vol: 36%). Co reported earnings last night. $AVTR Nov 20.5 puts (volume: 39.8K, open int: 10, implied vol: ~32%, prev day implied vol: 29%). 28.5K traded in a single transaction. Co reported earnings before the open.

User Image TeresaTrades Posted - 10/25/24

Heavy options volume $IBRX $EVLV $NWL $AVTR $CPRI

User Image briefingcom Posted - 10/25/24

$AVTR: Avantor beats by $0.01, reports revs in-line https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241025060838AVTR&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image DonCorleone77 Posted - 10/25/24

$AVTR Avantor reports Q3 adjusted EPS 26c, consensus 25c Reports Q3 revenue $1.71B, consensus $1.73B. "Our team delivered another quarter of solid financial results, including outperformance in bioprocessing and a return to growth in our laboratory solutions segment. Our disciplined approach to working capital drove another quarter of best-in-class free cash flow conversion and we are raising our free cash flow guidance for the year," said Michael Stubblefield, president and CEO.

User Image AivelX Posted - 10/24/24

💡 #AivelX Premarket Earnings Insights $AVTR - Ref.Earnings: 26 Gap Up Prob.: 31%, max 3.1%, min -19.9%, avg -1.6% Avg Low vs Open: -5.9% Avg Close vs Low: 3.7% Avg Low-High %: 9.4% 5 Days Later: 42% new highs, 62% new lows Earnings Day: 96% broke 24.1 (+2.9%) $HCA - Ref.Earnings: 128 Gap Up Prob.: 38%, max 2.9%, min -19.9%, avg -1% Avg Low vs Open: -3.5% Avg Close vs Low: 2% Avg Low-High %: 5% 5 Days Later: 59% new highs, 55% new lows Earnings Day: 43% broke 390.5 (-3%) #Earnings #Insights

User Image swingingtech Posted - 10/24/24

$MDYV $MIDD $HQY $AVTR https://wallstreetwaves.com/mdyv-holdings-forecasting-a-10-upside-potential/

User Image TeresaTrades Posted - 4 weeks ago

Largest PUT OI increases $LCID $AVTR $AMD $NVDA $CORZ

User Image WeeklyTrader Posted - 4 weeks ago

Don't get caught in $AVTR! RSI: 32.53% 50-day MA: $25.61 200-day MA: $24.24

User Image swingingtech Posted - 1 month ago

$APLD $AVTR $GOOGL https://wallstreetwaves.com/significant-tuesday-options-trading-apld-avtr-googl-insights/

User Image WeeklyTrader Posted - 1 month ago

Market jitters ahead! Consider a PUT on $AVTR at strike 24.0p. RSI: 44.8% 50-day MA: $25.64 200-day MA: $24.18

User Image Stock_Titan Posted - 09/27/24

$AVTR Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024 https://www.stocktitan.net/news/AVTR/avantor-r-to-host-third-quarter-2024-earnings-call-on-friday-october-e795hekoa33x.html

User Image TeresaTrades Posted - 09/26/24

Largest PUT OI increases $AVTR $NVDA $KSS $PFE $HUN

Analyst Ratings
RBC Capital Outperform Sep 26, 24
Wells Fargo Overweight Aug 27, 24
TD Cowen Buy Jul 29, 24
Morgan Stanley Overweight Jul 29, 24
Barclays Overweight Jul 29, 24
RBC Capital Outperform Jul 29, 24
Stifel Buy Jul 29, 24
Baird Outperform Jul 29, 24
RBC Capital Outperform Jul 15, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Couturier Christophe EVP, AMEA EVP, AMEA Apr 11 Sell 21.18 1,498 31,728 98,650 04/13/23
Couturier Christophe EVP, AMEA EVP, AMEA Feb 23 Sell 24.24 3,078 74,611 94,370 02/27/23
Brophy Gerard EVP, Biopharma Produ.. EVP, Biopharma Production Jan 31 Sell 25.06 11,339 284,155 102,385 02/02/23
Brophy Gerard EVP, Biopharma Produ.. EVP, Biopharma Production May 20 Sell 31.27 19,603 612,986 96,935 05/23/22
Vanderhaegen Frederic EVP, Americas & Euro.. EVP, Americas & Europe May 23 Sell 31.61 39,000 1,232,790 126,764 05/23/22
Brophy Gerard EVP, Biopharma Produ.. EVP, Biopharma Production Mar 01 Sell 34.47 2,027 69,871 136,221 03/02/22
Brophy Gerard EVP, Biopharma Produ.. EVP, Biopharma Production Feb 23 Sell 33.79 3,059 103,364 125,181 02/25/22
GUPTA RAJIV Director Director May 26 Sell 31.66 337,571 10,687,498 506,218 05/26/21
Natauri Jo Director Director May 13 Sell 30.68 2,626,771 80,589,334 24,807,518 05/13/21
Ohri Devashish EVP, IMEA EVP, IMEA Apr 13 Option 1.6 100,160 160,256 256,048 04/13/21
Vanderhaegen Frederic EVP, Europe EVP, Europe Apr 13 Sell 31.79 27,075 860,714 216,594 04/13/21
Wondrasch Michael EVP & CIO EVP & CIO Feb 08 Option 23.2 40,000 928,000 181,543 02/08/21
Wondrasch Michael EVP & CIO EVP & CIO Feb 08 Sell 29.77 49,468 1,472,662 141,543 02/08/21
Brophy Gerard EVP, Biopharma Produ.. EVP, Biopharma Production Jan 13 Option 23.2 378,580 8,783,056 340,763 01/13/21
Brophy Gerard EVP, Biopharma Produ.. EVP, Biopharma Production Jan 13 Sell 30.06 378,580 11,380,115 178,515 01/13/21
Stubblefield Michael President and CEO President and CEO Dec 08 Option 1.6 1,090,970 1,745,552 1,945,717 12/08/20
Stubblefield Michael President and CEO President and CEO Dec 08 Sell 27.27 510,640 13,925,153 1,847,265 12/08/20
Natauri Jo Director Director Nov 12 Buy 17.15 15,199 260,663 58,861,148 11/12/20
Natauri Jo Director Director Nov 12 Sell 17.18 39,118 672,047 58,861,086 11/12/20
Ohri Devashish EVP, IMEA EVP, IMEA Oct 07 Option 1.6 103,440 165,504 201,671 10/07/20
Ohri Devashish EVP, IMEA EVP, IMEA Oct 07 Sell 23.45 103,440 2,425,668 151,671 10/07/20